| Net loss | |
| Unrealized gain on derivative instruments | |
| Depreciation and amortization | 4K |
| Loss on equity method investment | |
| Employee stock option expense | 970K |
| Asset write down | |
| Deferred income tax expense (benefit) | |
| Amortization of discount on long-term debt | |
| (Gain) on asset and equity security sales | |
| Prepaid expenses and other current assets | 31K |
| Accounts payable and other current liabilities | |
| Net cash used in operating activities | -1.44M |
| Additions to mineral properties | |
| Additions to other assets | |
| Proceeds from sale of marketable equity securities | 56K |
| Proceeds from sale of other assets | |
| Net cash provided by investing activities | -15.76M |
| Short-term borrowing | |
| Repayment of short-term borrowing | |
| Repayment of long-term debt | |
| Proceeds from common stock offering, net | |
| Noncontrolling interest contribution | |
| Proceeds on exercise of options | |
| Payment to noncontrolling investor | |
| Net cash provided by financing activities | -214K |
| Net increase (decrease) in cash and cash equivalents | -17.41M |
| Cash and cash equivalents, beginning of period | 17.72M |
| Cash and cash equivalents, end of period | 307K |
| Reclassification of stock option liability to additional paid-in-capital | |
| Reclassification of stock option liability to accumulated deficit, net of deferred taxes of $543 | |